Inhaled corticosteroid treatment and pneumonia in patients with chronic obstructive pulmonary disease–nationwide development from 1998 to 2018
A Klitgaard, R Ibsen, J Lykkegaard… - European Clinical …, 2024 - Taylor & Francis
Background A decreasing use of inhaled corticosteroids (ICS) in patients with a hospital-
registered diagnosis of chronic obstructive pulmonary disease (COPD) has recently been …
registered diagnosis of chronic obstructive pulmonary disease (COPD) has recently been …
Impact of triple therapy vs dual bronchodilator therapy on mortality rates in COPD
DJ Tan, WH van Geffen, EH Walters - Chest, 2024 - journal.chestnet.org
In our study, we report most of our results combined for all three biologic drug classes.
Because there are set and agreed criteria for prescribing each biologic in Denmark and …
Because there are set and agreed criteria for prescribing each biologic in Denmark and …
Pulmonology: What You May Have Missed in 2023
A Karkar, S Khan, R O'Leary, A Tyker… - Annals of Internal …, 2024 - acpjournals.org
The field of pulmonology saw significant advances in 2023. The publications highlighted in
this article address advances and changes in practice related to asthma, chronic obstructive …
this article address advances and changes in practice related to asthma, chronic obstructive …
[PDF][PDF] A comparative study on safety profile and efficacy of salmeterol and tiotropium in COPD Patients
K Jagadeesh, R Vandana, BA Varun, G Vinod… - 2024 - wjarr.com
Abstract Aim and Objectives: The aim of the study is assess the safety profile and efficacy of
salmeterol and Tiotropium in patients with COPD. The objective is to compare to evaluate …
salmeterol and Tiotropium in patients with COPD. The objective is to compare to evaluate …